Considering the next two enzymes involved in the glycolysis pathway, i.e., glucose-6-phosphate isomerase and phosphofructokinase 1 (PFK1), no reports of potential inhibitors of these enzymes in the field of cancer cell metabolism have been found to date. This evidence concerns the gene PFKM and cancer.